| Income Statement |
| Total Revenue | 24.26M |
|
| Revenues (USD) | 24.26M |
| Cost of Revenue | 8.81M |
| Gross Profit | 15.46M |
| Operating Expenses | 37.59M |
| Research and Development Expense | 5.87M |
| Selling, General and Administrative Expense | 21.43M |
| Operating Income | -22.14M |
| Interest Expense | 272.00K |
| Income Tax Expense | -313.00K |
| Net Income | -22.16M |
| Net Income Common Stock | -22.16M |
| Net Income Common Stock (USD) | -22.16M |
| Consolidated Income | -22.16M |
| Earnings per Basic Share | -0.24 |
| Earnings per Basic Share (USD) | -0.24 |
| Earnings per Diluted Share | -0.24 |
| Earning Before Interest & Taxes (EBIT) | -22.20M |
| Earning Before Interest & Taxes (USD) | -22.20M |
| Weighted Average Shares | 94.03M |
| Weighted Average Shares Diluted | 94.03M |
| Balance Sheet |
| Cash and Equivalents | 12.71M |
| Cash and Equivalents (USD) | 12.71M |
| Trade and Non-Trade Receivables | 28.04M |
| Current Assets | 47.48M |
| Property, Plant & Equipment Net | 9.11M |
| Total Assets | 148.49M |
| Debt Current | 45.47M |
| Total Debt | 45.47M |
| Current Liabilities | 100.54M |
| Total Liabilities | 110.63M |
| Accumulated Retained Earnings (Deficit) | -620.68M |
| Accumulated Other Comprehensive Income | 896.00K |
| Shareholders Equity | 37.87M |
| Shareholders Equity (USD) | 37.87M |
| Assets Non-Current | 101.01M |
| Total Debt (USD) | 45.47M |
| Deferred Revenue | 12.17M |
| Goodwill and Intangible Assets | 83.70M |
| Liabilities Non-Current | 10.09M |
| Trade and Non-Trade Payables | 15.05M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 5.97M |
| Net Cash Flow from Financing | 9.35M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.66M |
| Capital Expenditure | -1.49M |
| Issuance (Purchase) of Equity Shares | 9.38M |
| Net Cash Flow from Investing | -1.49M |
| Net Cash Flow from Operations | -10.63M |
| Effect of Exchange Rate Changes on Cash | 123.00K |
| Share Based Compensation | 1.48M |